TNF-话题@MedSci

#TNF#

224篇内容 | 3910人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1401645, encodeId=5b151401645a4, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=Mol Med Rep：TNFSF4与BLK基因多样性的关系以及对过敏性鼻炎的易感性, objectType=article, longId=105958, objectId=d4df10595833, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4df10595833, replyNumber=0, likeNumber=127, createdTime=2017-07-20, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4df10595833, moduleTitle=Mol Med Rep：TNFSF4与BLK基因多样性的关系以及对过敏性鼻炎的易感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4df10595833)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401644, encodeId=6a0a14016449d, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=Rheumatology：警惕！TNF抑制剂对中轴脊椎关节炎患者可能存在原发性失效, objectType=article, longId=103067, objectId=703c10306ef8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=703c10306ef8, replyNumber=0, likeNumber=60, createdTime=2017-06-24, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=703c10306ef8, moduleTitle=Rheumatology：警惕！TNF抑制剂对中轴脊椎关节炎患者可能存在原发性失效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=703c10306ef8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401643, encodeId=250414016434d, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=TNFα抑制剂治疗RA依然有突破性进展, objectType=article, longId=102184, objectId=9ce5102184a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ce5102184a3, replyNumber=0, likeNumber=87, createdTime=2017-06-18, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ce5102184a3, moduleTitle=TNFα抑制剂治疗RA依然有突破性进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ce5102184a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401642, encodeId=cfac1401642c2, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=Nature Medicine：针对使用中和TNF抗体无效的炎症性肠病的新方法, objectType=article, longId=98038, objectId=877098038e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=877098038e7, replyNumber=0, likeNumber=62, createdTime=2017-05-08, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=877098038e7, moduleTitle=Nature Medicine：针对使用中和TNF抗体无效的炎症性肠病的新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=877098038e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401641, encodeId=019a1401641c7, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=J Rheumatol：三联口服治疗与抗TNF联合MTX治疗MTX不应性类风湿的疗效比较, objectType=article, longId=96790, objectId=e66896e90a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e66896e90a6, replyNumber=0, likeNumber=62, createdTime=2017-04-24, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e66896e90a6, moduleTitle=J Rheumatol：三联口服治疗与抗TNF联合MTX治疗MTX不应性类风湿的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e66896e90a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401640, encodeId=256114016406e, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=Oral Dis：TNF可作为白血病患者化疗后口腔念珠菌病、HSV感染和粘膜病发病的指征, objectType=article, longId=96095, objectId=70d9960950c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70d9960950c, replyNumber=0, likeNumber=53, createdTime=2017-04-21, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70d9960950c, moduleTitle=Oral Dis：TNF可作为白血病患者化疗后口腔念珠菌病、HSV感染和粘膜病发病的指征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70d9960950c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401639, encodeId=788a140163981, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=Diabetes：TNF-α促进PIKE-A和AMPK之间的相互作用抑制骨骼肌脂质氧化！, objectType=article, longId=96058, objectId=092b9605831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=092b9605831, replyNumber=0, likeNumber=49, createdTime=2017-04-18, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=092b9605831, moduleTitle=Diabetes：TNF-α促进PIKE-A和AMPK之间的相互作用抑制骨骼肌脂质氧化！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=092b9605831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401638, encodeId=5fce140163899, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=NSAIDs和TNFi治疗可协同延缓AS的进展, objectType=article, longId=82447, objectId=ce8e8244e14, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce8e8244e14, replyNumber=0, likeNumber=66, createdTime=2016-11-17, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce8e8244e14, moduleTitle=NSAIDs和TNFi治疗可协同延缓AS的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce8e8244e14)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401637, encodeId=3946140163e3e, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=抗TNF治疗会增加AS、PsA、SpA患者的结核病风险, objectType=article, longId=82440, objectId=1950824406e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1950824406e, replyNumber=0, likeNumber=80, createdTime=2016-11-17, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1950824406e, moduleTitle=抗TNF治疗会增加AS、PsA、SpA患者的结核病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1950824406e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401636, encodeId=1fd6140163644, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=2016NICE技术评估指南：Secukinumab用于非甾体类抗炎药或TNF抑制剂治疗后强直性脊柱炎活动期的治疗（TA407）发布, objectType=article, longId=81136, objectId=2d358113649, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d358113649, replyNumber=0, likeNumber=65, createdTime=2016-10-28, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d358113649, moduleTitle=2016NICE技术评估指南：Secukinumab用于非甾体类抗炎药或TNF抑制剂治疗后强直性脊柱炎活动期的治疗（TA407）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d358113649)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401635, encodeId=82741401635ea, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=2016NICE技术评估指南：Certolizumab pego用于治疗TNFα抑制剂治疗反应不敏感类风湿性关节炎（TA415）发布, objectType=article, longId=81115, objectId=cd38811156e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd38811156e, replyNumber=0, likeNumber=24, createdTime=2016-10-28, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd38811156e, moduleTitle=2016NICE技术评估指南：Certolizumab pego用于治疗TNFα抑制剂治疗反应不敏感类风湿性关节炎（TA415）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd38811156e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401634, encodeId=56dc140163400, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=中国科学家在TNF疫苗研究方向取得创新性突破成果, objectType=article, longId=80669, objectId=7d4f80669d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d4f80669d9, replyNumber=0, likeNumber=67, createdTime=2016-10-23, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d4f80669d9, moduleTitle=中国科学家在TNF疫苗研究方向取得创新性突破成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d4f80669d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401633, encodeId=8b5f140163302, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=中国科学家李荣秀等在TNF疫苗研究方向取得创新性突破成果, objectType=article, longId=80456, objectId=ff6880456c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff6880456c3, replyNumber=0, likeNumber=81, createdTime=2016-10-21, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff6880456c3, moduleTitle=中国科学家李荣秀等在TNF疫苗研究方向取得创新性突破成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff6880456c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401632, encodeId=c54b140163263, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=Ann Surg：回结肠克罗恩病术前抗TNF治疗会增加术后并发症风险, objectType=article, longId=80207, objectId=125b8020e3d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=125b8020e3d, replyNumber=0, likeNumber=51, createdTime=2016-10-18, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=125b8020e3d, moduleTitle=Ann Surg：回结肠克罗恩病术前抗TNF治疗会增加术后并发症风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=125b8020e3d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401631, encodeId=564014016314c, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=JAMA：对TNFα抑制剂反应不足的类风湿性关节炎患者或可选择非TNF生物制剂, objectType=article, longId=78345, objectId=2e99e834555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e99e834555, replyNumber=0, likeNumber=65, createdTime=2016-09-26, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e99e834555, moduleTitle=JAMA：对TNFα抑制剂反应不足的类风湿性关节炎患者或可选择非TNF生物制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e99e834555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401630, encodeId=95fb1401630c7, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=Lancet：类风湿性关节炎生物制剂初始治疗：利妥昔单抗or TNF抑制剂？, objectType=article, longId=78325, objectId=ce07e832592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce07e832592, replyNumber=0, likeNumber=67, createdTime=2016-09-25, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce07e832592, moduleTitle=Lancet：类风湿性关节炎生物制剂初始治疗：利妥昔单抗or TNF抑制剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce07e832592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401629, encodeId=419c1401629d4, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=Am J Gastroenterol：遗传风险评分预测CD患者对抗-TNF治疗的应答情况, objectType=article, longId=77982, objectId=1e2de7982cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e2de7982cd, replyNumber=0, likeNumber=64, createdTime=2016-09-22, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e2de7982cd, moduleTitle=Am J Gastroenterol：遗传风险评分预测CD患者对抗-TNF治疗的应答情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e2de7982cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401628, encodeId=124e1401628db, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=Am J Gastroenterol：受孕前使用了抗TNF-α药物，孩子能不能要？, objectType=article, longId=77960, objectId=ba85e7960a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba85e7960a1, replyNumber=0, likeNumber=46, createdTime=2016-09-22, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba85e7960a1, moduleTitle=Am J Gastroenterol：受孕前使用了抗TNF-α药物，孩子能不能要？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba85e7960a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401627, encodeId=845f140162e36, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=优时比TNF抑制剂Cimzia获英国NICE批准用于类风湿性关节炎, objectType=article, longId=73296, objectId=60f9e329641, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60f9e329641, replyNumber=0, likeNumber=48, createdTime=2016-07-22, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60f9e329641, moduleTitle=优时比TNF抑制剂Cimzia获英国NICE批准用于类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60f9e329641)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401626, encodeId=8fa0140162615, content=<a href='/topic/show?id=17e21e57943' target=_blank style='color:#2F92EE;'>#TNF#</a>, objectTitle=Arthritis Rheum：RA患者暴露于TNFi，不会增加缺血性卒中风险, objectType=article, longId=72722, objectId=1ff4e272219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ff4e272219, replyNumber=0, likeNumber=53, createdTime=2016-07-14, rootId=0, userName=snowpeakxu, userId=e4fb2361580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ff4e272219, moduleTitle=Arthritis Rheum：RA患者暴露于TNFi，不会增加缺血性卒中风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ff4e272219)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

TNF

2020-05-29

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

Mol Med Rep：TNFSF4与BLK基因多样性的关系以及对过敏性鼻炎的易感性

2017-07-20

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

Rheumatology：警惕！TNF抑制剂对中轴脊椎关节炎患者可能存在原发性失效

2017-06-24

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

TNFα抑制剂治疗RA依然有突破性进展

2017-06-18

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

Nature Medicine：针对使用中和TNF抗体无效的炎症性肠病的新方法

2017-05-08

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

J Rheumatol：三联口服治疗与抗TNF联合MTX治疗MTX不应性类风湿的疗效比较

2017-04-24

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

Oral Dis：TNF可作为白血病患者化疗后口腔念珠菌病、HSV感染和粘膜病发病的指征

2017-04-21

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

Diabetes：TNF-α促进PIKE-A和AMPK之间的相互作用抑制骨骼肌脂质氧化！

2017-04-18

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

NSAIDs和TNFi治疗可协同延缓AS的进展

2016-11-17

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

抗TNF治疗会增加AS、PsA、SpA患者的结核病风险

2016-11-17

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

2016NICE技术评估指南：Secukinumab用于非甾体类抗炎药或TNF抑制剂治疗后强直性脊柱炎活动期的治疗（TA407）发布

2016-10-28

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

2016NICE技术评估指南：Certolizumab pego用于治疗TNFα抑制剂治疗反应不敏感类风湿性关节炎（TA415）发布

2016-10-28

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

中国科学家在TNF疫苗研究方向取得创新性突破成果

2016-10-23

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

中国科学家李荣秀等在TNF疫苗研究方向取得创新性突破成果

2016-10-21

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

Ann Surg：回结肠克罗恩病术前抗TNF治疗会增加术后并发症风险

2016-10-18

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

JAMA：对TNFα抑制剂反应不足的类风湿性关节炎患者或可选择非TNF生物制剂

2016-09-26

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

Lancet：类风湿性关节炎生物制剂初始治疗：利妥昔单抗or TNF抑制剂？

2016-09-25

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

Am J Gastroenterol：遗传风险评分预测CD患者对抗-TNF治疗的应答情况

2016-09-22

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

Am J Gastroenterol：受孕前使用了抗TNF-α药物，孩子能不能要？

2016-09-22

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

优时比TNF抑制剂Cimzia获英国NICE批准用于类风湿性关节炎

2016-07-22

snowpeakxu (审核中...)

前往app查看评论内容

#TNF#

Arthritis Rheum：RA患者暴露于TNFi，不会增加缺血性卒中风险

2016-07-14

科室
- - 订阅+
  - 更多科室
工具
服务